Market Overview:
The global controlled release drug delivery market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising demand for advanced drug delivery systems, and technological advancements in the field of controlled release drug delivery. Based on type, the global controlled release drug delivery market is segmented into wurster technique, coacervation, micro encapsulation, implants, transdermal, targeted delivery and others. The implant segment is expected to grow at a highest CAGR during the forecast period from 2018 to 2030 owing to its advantages such as improved patient compliance and reduced side effects as compared with other types of controlled release drug delivery systems.
Product Definition:
Controlled release drug delivery is a method of administering medication in which the drug is released slowly and continuously over a period of time. This type of delivery system can be helpful in controlling the dosage and timing of medication administration, as well as reducing side effects.
Wurster Technique:
Wurster technique is a method of preparing highly porous and permeable drug delivery systems. The technique involves the use of anionic polymerization to create spherulites (small spherical particles) from which the drug can be incorporated. These spheres are then treated with alkali or acid to make them permeable, and they are used as carriers for drugs that do not dissolve easily in water or other solvents.
Coacervation:
Coacervation is a process of creating highly stable and long-lasting emulsions by the interaction between an oil phase and a water-based Phase. Coacervates are formed when the drug in an oil-water emulsion undergoes rapid equilibration, leading to its deposition in the water phase. The coacervate is then collected and processed to yield high purity final product with enhanced properties such as extended shelf life & low toxicity.
Application Insights:
Metered dose inhalers (MDIs) were the largest application segment in the global controlled release drug delivery market, accounting for over 45% of the revenue share in 2017. The segment is expected to continue its dominance over the forecast period owing to factors such as high prevalence of asthma and chronic respiratory diseases coupled with increasing number of MDI launches.
The injectables application segment is also expected to grow at a lucrative rate during the forecast period due to factors such as increasing geriatric population, cancer cases, and other medical conditions that require long-term medication. Moreover, an increase in research & development activities by major players for new product launch related to controlled release injectables will further boost growth during future years.
Owing to growing geriatric population across various regions including North America.
Regional Analysis:
North America dominated the global market in 2017. The dominance of this region is majorly attributed to factors such as the presence of key players, high disposable income, and favorable reimbursement policies. In addition, increasing R&D activities for CVDDs are also expected to drive growth during the forecast period. Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as rising healthcare expenditure and improving healthcare infrastructure in emerging countries like China and India.
Major companies include but are not limited to; Johnson & Johnson Services Inc.; Unilife Corporation; Alkermes plc; Pfizer Inc.; Allergan PLC; Actavis plc; Endo Health Solutions LLC.; Orthofix Holdings Inc.; Mylan N.V., among others (see Table 1).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyle and dietary habits of people across the world. The rise in the number of people suffering from chronic diseases has led to an increase in the demand for controlled release drug delivery systems, as they help in delivering drugs to patients in a more targeted manner.
- Technological advancements: The controlled release drug delivery market is witnessing rapid technological advancements, with new and innovative products being launched on a regular basis. This is helping to boost the growth of this market considerably.
- Rising demand for minimally invasive procedures: There has been a rising demand for minimally invasive procedures across the world in recent years due to their many advantages over traditional surgical procedures such as shorter recovery time and reduced pain and scarring. Controlled release drug delivery systems are increasingly being used during these minimally invasive procedures as they help reduce complications associated with them and improve patient outcomes overall..
Scope Of The Report
Report Attributes
Report Details
Report Title
Controlled Release Drug Delivery Market Research Report
By Type
Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Others
By Application
Metered Dose Inhalers, Injectables, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-Drug Delivery Systems, Drug Eluting Stents
By Companies
Depomed, Coating Place, Corium, Johnson and Johnson, Alkermes, Pfizer, Orbis Biosciences, Capsugel, Merck, Aradigm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Controlled Release Drug Delivery Market Report Segments:
The global Controlled Release Drug Delivery market is segmented on the basis of:
Types
Wurster Technique, Coacervation, Micro Encapsulation, Implants, Transdermal, Targeted Delivery, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Metered Dose Inhalers, Injectables, Transdermal and Ocular Patches, Infusion Pumps, Oral Controlled-Drug Delivery Systems, Drug Eluting Stents
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Depomed
- Coating Place
- Corium
- Johnson and Johnson
- Alkermes
- Pfizer
- Orbis Biosciences
- Capsugel
- Merck
- Aradigm
Highlights of The Controlled Release Drug Delivery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Wurster Technique
- Coacervation
- Micro Encapsulation
- Implants
- Transdermal
- Targeted Delivery
- Others
- By Application:
- Metered Dose Inhalers
- Injectables
- Transdermal and Ocular Patches
- Infusion Pumps
- Oral Controlled-Drug Delivery Systems
- Drug Eluting Stents
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Controlled Release Drug Delivery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Controlled release drug delivery is a method of delivering drugs to the body that allows for consistent and predictable dosing over time. Controlled release formulations allow for the drug to be released slowly over an extended period of time, which can reduce the potential side effects associated with traditional dosages.
Some of the major companies in the controlled release drug delivery market are Depomed, Coating Place, Corium, Johnson and Johnson, Alkermes, Pfizer, Orbis Biosciences, Capsugel, Merck, Aradigm.
The controlled release drug delivery market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Controlled Release Drug Delivery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Controlled Release Drug Delivery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Controlled Release Drug Delivery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Controlled Release Drug Delivery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Controlled Release Drug Delivery Market Size & Forecast, 2020-2028
4.5.1 Controlled Release Drug Delivery Market Size and Y-o-Y Growth
4.5.2 Controlled Release Drug Delivery Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Wurster Technique
5.2.2 Coacervation
5.2.3 Micro Encapsulation
5.2.4 Implants
5.2.5 Transdermal
5.2.6 Targeted Delivery
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Metered Dose Inhalers
6.2.2 Injectables
6.2.3 Transdermal and Ocular Patches
6.2.4 Infusion Pumps
6.2.5 Oral Controlled-Drug Delivery Systems
6.2.6 Drug Eluting Stents
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Controlled Release Drug Delivery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Controlled Release Drug Delivery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Wurster Technique
9.6.2 Coacervation
9.6.3 Micro Encapsulation
9.6.4 Implants
9.6.5 Transdermal
9.6.6 Targeted Delivery
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Metered Dose Inhalers
9.10.2 Injectables
9.10.3 Transdermal and Ocular Patches
9.10.4 Infusion Pumps
9.10.5 Oral Controlled-Drug Delivery Systems
9.10.6 Drug Eluting Stents
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Wurster Technique
10.6.2 Coacervation
10.6.3 Micro Encapsulation
10.6.4 Implants
10.6.5 Transdermal
10.6.6 Targeted Delivery
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Metered Dose Inhalers
10.10.2 Injectables
10.10.3 Transdermal and Ocular Patches
10.10.4 Infusion Pumps
10.10.5 Oral Controlled-Drug Delivery Systems
10.10.6 Drug Eluting Stents
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Wurster Technique
11.6.2 Coacervation
11.6.3 Micro Encapsulation
11.6.4 Implants
11.6.5 Transdermal
11.6.6 Targeted Delivery
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Metered Dose Inhalers
11.10.2 Injectables
11.10.3 Transdermal and Ocular Patches
11.10.4 Infusion Pumps
11.10.5 Oral Controlled-Drug Delivery Systems
11.10.6 Drug Eluting Stents
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Wurster Technique
12.6.2 Coacervation
12.6.3 Micro Encapsulation
12.6.4 Implants
12.6.5 Transdermal
12.6.6 Targeted Delivery
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Metered Dose Inhalers
12.10.2 Injectables
12.10.3 Transdermal and Ocular Patches
12.10.4 Infusion Pumps
12.10.5 Oral Controlled-Drug Delivery Systems
12.10.6 Drug Eluting Stents
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Wurster Technique
13.6.2 Coacervation
13.6.3 Micro Encapsulation
13.6.4 Implants
13.6.5 Transdermal
13.6.6 Targeted Delivery
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Metered Dose Inhalers
13.10.2 Injectables
13.10.3 Transdermal and Ocular Patches
13.10.4 Infusion Pumps
13.10.5 Oral Controlled-Drug Delivery Systems
13.10.6 Drug Eluting Stents
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Controlled Release Drug Delivery Market: Competitive Dashboard
14.2 Global Controlled Release Drug Delivery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Depomed
14.3.2 Coating Place
14.3.3 Corium
14.3.4 Johnson and Johnson
14.3.5 Alkermes
14.3.6 Pfizer
14.3.7 Orbis Biosciences
14.3.8 Capsugel
14.3.9 Merck
14.3.10 Aradigm
